Virtual agent helps DynaLIFE deliver COVID-19 testing service
DynaLIFE is a major Canadian medical laboratory offering diagnostic testing services to Albertans. When its new COVID-19 test option for travelers caused a surge in contact center demand, CGI helped alleviate the burden with a conversational chatbot, or virtual agent. ...
Enabling effective, population-centric COVID-19 vaccination programs
How will jurisdictions confidently and efficiently predict demand, order vaccines, and inoculate populations to meet their goals? Fortunately, there are proven practices, tools and technologies that can help organizations improve their effectiveness in these endeavors.700+
biotech/pharmaceutical projects completed for 50 clients
Millions
of Danes benefit from a CGI-developed system for pathology
11
of the top 20 biotech and pharmaceutical clients served globally
CGI expertise and services help life sciences organizations increase speed, efficiency and innovation, while keeping pace with compliance demands. Key capabilities include:
-
Commercial launch and operations to simplify planning and execution and improve launch efficiency
-
Clinical services to reduce the duration of drug development timelines
-
Manufacturing innovation to achieve end-to-end supply chain optimization, manufacturing execution excellence, transport management and ERP, including Industry 4.0
-
Regulatory compliance to help clients continuously monitor clinical drug safety data across the entire product life cycle
-
Outsourcing to improve the management and operation of company-wide infrastructures, application suites and business processes
-
Intelligent automation to increase efficiency of operations by combining advanced analytics with IoT and AI for predictive maintenance
Explore enabling technologies
CGI solutions and services also have supported:
-
For an international Swiss pharmaceutical company, data cleansing as a part of data migration process
-
For an international pharmaceutical company, bringing product to market faster and more effectively through design, implementation and maintenance of an integrated clinical portfolio framework and architecture
-
For a global pharmaceutical company headquartered in Germany, maintenance and development of a risk management tool, knowledge management application and software solution to manage biological entities
Related media
Webinar recording: Factors for a Successful COVID-19 Vaccination Program
Charting the path forward with resilience and adaptability
Annually,
CGI
leaders
around
the
world
meet
face-to-face
with
business
and
IT
executives
to
gather
their
perspectives
on
the
trends
affecting
their
enterprises,
including
business
and
IT
priorities,
IT
spending,
...
FAIRFAX,
VA
,
May
7,
2020
-
CGI
(NYSE:
GIB)
(TSX:
GIB.
A)
today
announced
the
award
of
a
5-year
contract
from
NetApp,
a
leading
cloud
data
...
March
23,
2020
MONTREAL
--
The
Montreal
Heart
Institute
announces
that
its
Research
Center
is
launching
today
a
COVID-19
clinical
study
in
Canada
to
determine
whether
short-term
...
As
the
COVID-19
pandemic
rapidly
spread
across
the
globe
in
the
early
months
of
2020,
the
Montreal
Heart
Institute
(MHI)
responded
by
launching
a
major
clinical
study
to
test
a
...
In
2019,
as
presented
in
our
CGI
Client
Global
Insights,
we
spoke
in
person
with
more
than
1,550
executives
across
10
industries
to
gather
their
perspectives
on
the
trends
affecting
...